The 1st truly sterile bio burden free ophthalmic products introduced for your recommendation
Quinoflox
ciorofloxacin U.S.P . 0.3%
. The comprehensive antibiotic coverage
. Pre & post operative control of infections.
. Corneal ulcers & bacterial conjunctivitis. . Effectively penetrates into body tissues & fluids.
. Lower MICs against most ocular pathogens.
Indications.
. Preoperativerly for prophylaxis of infection.
. post operativerly to treat bacterial infection.
.Mucopurulent conjuctivitis, acute and subacute conjunctivitis,bacterial keratitis,bacterial corneal ulcer.
Dose:2-3 drops 2-3 times daily.
Expertise & Science Now in ophthalmic Manufacturing
1st TIme Introducing
Nitrofresh Technology in Ophthalmic Manufacturing.
The Science if Nitrofresh Technology is Purging of empty space with nitrogen to make the cial oxygen free
The advantages.
> Keep the prduct fresh,100% active drug content upon opeming.
>Sace the product from any kind of contamination.
>Safe from oqygen induced chemical reactions.
Filling in particle free highly sterilized areas
>These highly sterilized filling areas (Known as class 100 ) having laminar flow provides,
Zero particle count and continuously monitored by fully automatic computerized units.
Tariflox
(Oflixacin)
Dexamex
(Dexamethasone sodium phosphate)
Quinofox
(Ciprofloxacin)
`
Plant Head Office :
8, Modern Society, Tipu Sultan Road, Karachi, 75350, Pakistan, Tel:0800-26724,(021) 4541876
Fax:(9221)4545915